Moderna, Inc. remains under pressure in 2025, despite recent next-gen COVID vaccine approval & cancer vaccine trial. Learn ...

CAMBRIDGE, MA / ACCESS Newswire / October 16, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, November 6, 2025 to ...

Moderna's decision not to diversify outside of COVID has hurt its business substantially. The company is still generating ...

Studies are sounding alarm bells regarding the safety of COVID-19 mRNA vaccines, particularly in light of new findings linking these injections to an increased risk of myocarditis, a potentially fatal ...

It’s that time of year when the leaves are turning golden, there’s a chill in the air and the threat of respiratory viruses ...

Moderna Inc said on Monday it has applied for U.S. emergency authorization for its COVID-19 vaccine after full results from a late-stage study showed it was 94.1% effective with no serious safety ...

Moderna Inc said on Monday its experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage clinical trial, becoming the second U.S. company in a week to ...

When it comes to seasonal viruses, the big three are the flu, COVID and respiratory syncytial virus, or RSV for short. Here's what you need to know about RSV protection and the vaccines ...

Researchers at the University of Maryland School of Medicine’s Center for Vaccine Development and Global Health (CVD) have completed a successful Phase 1 clinical trial of a novel vaccine designed to ...

The CDC pulled broad support for COVID-19 shots, saying they should be administered through shared decision-making with a ...

(Reuters) -A top U.S. health official on Monday called for the combined measles-mumps-rubella shot to be broken up, drawing a ...

A top U.S. health official today called for the combined measles-mumps-rubella shot to be broken up, drawing a quick rebuke ...